Clinical Trial Update: Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH) [Phase 4]

View source ↗

Summary

Phase 4 trial results assess the effects of exenatide (Byetta) on liver function in patients with nonalcoholic steatohepatitis (NASH); the study status is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• BYETTA (Exenatide)

Snippet

Sponsor: Ruhr University of Bochum | Conditions: Nonalcoholic Fatty Liver Disease | Phase 4 | Status: COMPLETED